title: Japanese guideline for atopic dermatitis.
abstract: Given the importance of appropriate diagnosis and appropriate assessment of cutaneous symptoms in treatment of atopic dermatitis, the basics of treatment in this guideline are composed of (1) investigation and countermeasures of causes and exacerbating factors, (2) correction of skin dysfunctions (skin care), and (3) pharmacotherapy, as three mainstays. These are based on the disease concept that atopic dermatitis is a inflammatory cutaneous disease with eczema by atopic diathesis, multi-factorial in onset and aggravation, and accompanied by skin dysfunctions. These three points are equally important and should be appropriately combined in accordance with the symptoms of each patient. In treatment, it is important to transmit the etiological, pathological, physiological, or therapeutic information to the patient to build a favorable partnership with the patient or his/her family so that they may fully understand the treatment. This guideline discusses chiefly the basic therapy in relation to the treatment of this disease. The goal of treatment is to enable patients to lead an uninterrupted social life and to control their cutaneous symptoms so that their quality of life (QOL) may meet a satisfactory level.
authors.affiliation: Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Japan. katayama@derma.med.osaka−u.ac.jp
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Kohno
authors.forename: Kazuo
authors.initials: K
authors.lastname: Akiyama
authors.forename: Zenro
authors.initials: Z
authors.lastname: Ikezawa
authors.forename: Naomi
authors.initials: N
authors.lastname: Kondo
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Tamaki
authors.forename: Osamu
authors.initials: O
authors.lastname: Kouro
mesh_terms: D003876:Dermatitis, Atopic / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D018450:Disease Progression; D006801:Humans; D007564:Japan; D012017:Referral and Consultation; D012307:Risk Factors; D017592:Skin Care